Drug Profile
Zolmitriptan oral dispersible film
Alternative Names: zolmitriptan ODF; Zolmitriptan PharmaFilm; Zolmitriptan RapidFilm; Zolmitriptan Renantos 2.5mg Schmelzfilm; Zolmitriptan Renantos 5mg SchmelzfilmLatest Information Update: 13 Feb 2019
Price :
$50
*
At a glance
- Originator APR Applied Pharma Research; Labtec
- Developer APR Applied Pharma Research; Aquestive Therapeutics; tesa Labtec
- Class Analgesics; Antimigraines; Indoles; Oxazolidinones; Small molecules; Tryptamines
- Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Migraine
Most Recent Events
- 13 Feb 2019 Zolmitriptan oral dispersible film is not yet available for Migraine in United Kingdom
- 17 Apr 2015 Zolmitriptan oral dispersible film is approved in the European Union for Migraine
- 08 Feb 2012 Registered for Migraine in Austria (PO)